Steven C Gilman Vericel Corp (VCEL) insider trading activity

Steven C Gilman is of Vericel Corp. Currently has a direct ownership of 11,000 shares of VCEL, which is worth approximately $483,890. The most recent transaction as insider was on Oct 16, 2024, when has been sold 5,833 shares (Common Stock) at a price of $41.36 per share, resulting in proceeds of $241,252. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11K

0% 3M change

41.03% 12M change

Total Value Held $483,890

STEVEN C GILMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 16 2024	SELL Open market or private sale	$241,252 $41.36 p/Share	5,833 Reduced 34.65%	11,000 Common Stock
Oct 16 2024	BUY Exercise of conversion of derivative security	$76,120 $13.05 p/Share	5,833 Added 25.73%	16,833 Common Stock
Oct 02 2024	SELL Open market or private sale	$235,361 $40.35 p/Share	5,833 Reduced 34.65%	11,000 Common Stock
Oct 02 2024	BUY Exercise of conversion of derivative security	$76,120 $13.05 p/Share	5,833 Added 25.73%	16,833 Common Stock
Sep 18 2024	SELL Open market or private sale	$265,680 $45.54 p/Share	5,834 Reduced 34.66%	11,000 Common Stock
Sep 18 2024	BUY Exercise of conversion of derivative security	$76,133 $13.05 p/Share	5,834 Added 25.74%	16,834 Common Stock
Sep 04 2024	SELL Open market or private sale	$242,900 $48.58 p/Share	5,000 Reduced 31.25%	11,000 Common Stock
Sep 04 2024	BUY Exercise of conversion of derivative security	$18,700 $3.74 p/Share	5,000 Added 23.81%	16,000 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	3,200 Added 22.54%	11,000 Common Stock
Apr 27 2023	BUY Exercise of conversion of derivative security	-	2,600 Added 25.0%	7,800 Common Stock
Apr 29 2022	SELL Open market or private sale	$27,846 $30.94 p/Share	900 Reduced 14.75%	5,200 Common Stock
Apr 27 2022	BUY Exercise of conversion of derivative security	-	2,600 Added 29.89%	6,100 Common Stock
Nov 29 2021	SELL Open market or private sale	$195,850 $39.17 p/Share	5,000 Reduced 58.82%	3,500 Common Stock
Nov 29 2021	BUY Exercise of conversion of derivative security	$18,700 $3.74 p/Share	5,000 Added 37.04%	8,500 Common Stock
Oct 27 2021	SELL Open market or private sale	$252,850 $50.57 p/Share	5,000 Reduced 58.82%	3,500 Common Stock
Oct 27 2021	BUY Exercise of conversion of derivative security	$18,700 $3.74 p/Share	5,000 Added 37.04%	8,500 Common Stock
Sep 30 2021	SELL Open market or private sale	$244,250 $48.85 p/Share	5,000 Reduced 58.82%	3,500 Common Stock
Sep 30 2021	BUY Exercise of conversion of derivative security	$18,700 $3.74 p/Share	5,000 Added 37.04%	8,500 Common Stock
Apr 28 2021	BUY Exercise of conversion of derivative security	-	1,750 Added 33.33%	3,500 Common Stock

Also insider at

SCYX

SCYNEXIS INC Healthcare

CFRX

CONTRAFECT Corp Healthcare

Director

AKBA

Akebia Therapeutics, Inc. Healthcare

SCG

Steven C Gilman

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VCEL shares.

Notify only if

Value

Insider Trading

Get notified when an Vericel Corp insider buys or sells VCEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vericel Corp

Track Activities on VCEL

Account